Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ptc Therapeutics (PTCT) Total Non-Current Liabilities (2016 - 2025)

Ptc Therapeutics (PTCT) has 14 years of Total Non-Current Liabilities data on record, last reported at $3.1 billion in Q4 2025.

  • For Q4 2025, Total Non-Current Liabilities rose 11.1% year-over-year to $3.1 billion; the TTM value through Dec 2025 reached $3.1 billion, up 11.1%, while the annual FY2025 figure was $3.1 billion, 11.1% up from the prior year.
  • Total Non-Current Liabilities reached $3.1 billion in Q4 2025 per PTCT's latest filing, up from $2.8 billion in the prior quarter.
  • Across five years, Total Non-Current Liabilities topped out at $3.1 billion in Q4 2025 and bottomed at $1.6 billion in Q1 2021.
  • Average Total Non-Current Liabilities over 5 years is $2.3 billion, with a median of $2.0 billion recorded in 2022.
  • Peak YoY movement for Total Non-Current Liabilities: surged 174.26% in 2021, then decreased 2.7% in 2025.
  • A 5-year view of Total Non-Current Liabilities shows it stood at $1.7 billion in 2021, then rose by 20.83% to $2.1 billion in 2022, then soared by 32.39% to $2.7 billion in 2023, then rose by 2.49% to $2.8 billion in 2024, then rose by 11.1% to $3.1 billion in 2025.
  • Per Business Quant database, its latest 3 readings for Total Non-Current Liabilities were $3.1 billion in Q4 2025, $2.8 billion in Q3 2025, and $2.8 billion in Q2 2025.